A UK startup is literally taking medicine to new heights—sending drug-making into orbit. BioOrbit is pioneering space-based drug crystallization technology that could transform how we manufacture life-saving medications, starting with a self-injected cancer treatment.

The company believes that the microgravity environment of space offers unique conditions for growing drug crystals with superior properties compared to Earth-based production. This breakthrough approach has the potential to help millions of patients by creating more effective treatments with fewer side effects. The innovation represents a bold bet that extraterrestrial manufacturing could solve some of medicine's toughest challenges. Read the full story →

Today's takeaway: When innovation reaches for the stars, patients on Earth stand to benefit most.